Works by Jung-Im Na


Results: 60
    1

    A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibitor, in patients with mild to moderate atopic dermatitis: a proof-of-concept study with Post-hoc biomarker analysis

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1560447
    By:
    • Baek, Gyeong Ho;
    • Kim, Bo Ri;
    • Shin, Jung-Won;
    • Huh, Chang Hun;
    • Hwang, Jungjoong;
    • Ko, Sungmin;
    • Kim, Siwon;
    • Ho, Pil-Su;
    • Kim, Kyu-Han;
    • Park, Chun Wook;
    • Seo, Seong Jun;
    • Park, Chang-Ook;
    • Shin, Dongyoon;
    • Kim, Yeongshin;
    • Kim, Youngsoo;
    • Seong, Seung-Yong;
    • Na, Jung-Im
    Publication type:
    Article
    2
    3
    4
    5
    6

    Melasma: Updates and perspectives.

    Published in:
    Experimental Dermatology, 2019, v. 28, n. 6, p. 704, doi. 10.1111/exd.13844
    By:
    • Kwon, Soon‐Hyo;
    • Na, Jung‐Im;
    • Choi, Ji‐Young;
    • Park, Kyoung‐Chan
    Publication type:
    Article
    7
    8

    Stem cell recovering effect of copper-free GHK in skin.

    Published in:
    Journal of Peptide Science, 2012, v. 18, n. 11, p. 685, doi. 10.1002/psc.2455
    By:
    • Choi, Hye-Ryung;
    • Kang, Youn-A;
    • Ryoo, Sun-Jong;
    • Shin, Jung-Won;
    • Na, Jung-Im;
    • Huh, Chang-Hun;
    • Park, Kyoung-Chan
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50